Update of CVM's What's New - FDA Provides Equine Veterinarians with Important Information about TILDREN and OSPHOS for Navicular Syndrome in Horses

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: Update of CVM's What's New - FDA Provides Equine Veterinarians with Important Information about TILDREN and OSPHOS for Navicular Syndrome in Horses

You are subscribed to CVM What's New, for newly posted information on the U.S. Food & Drug Administration's (FDA) Center for Veterinary Medicine's (CVM) Website.

This information has recently been updated and is now available.

FDA Provides Equine Veterinarians with Important Information about TILDREN and OSPHOS for Navicular Syndrome in Horses – http://www.fda.gov/AnimalVeterinary/ResourcesforYou/ucm406581.htm

 

Visit our home page at http://www.fda.gov/AnimalVeterinary/default.htm

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? Please visit subscriberhelp.govdelivery.com
• Other inquiries? webmail@xxxxxxxxxx

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420